AU2002359792A8 - Methods and compositions for the inhibition of viral release - Google Patents

Methods and compositions for the inhibition of viral release

Info

Publication number
AU2002359792A8
AU2002359792A8 AU2002359792A AU2002359792A AU2002359792A8 AU 2002359792 A8 AU2002359792 A8 AU 2002359792A8 AU 2002359792 A AU2002359792 A AU 2002359792A AU 2002359792 A AU2002359792 A AU 2002359792A AU 2002359792 A8 AU2002359792 A8 AU 2002359792A8
Authority
AU
Australia
Prior art keywords
inhibition
compositions
methods
viral release
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359792A
Other versions
AU2002359792A1 (en
Inventor
Yuval Reiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteologics Inc
Original Assignee
Proteologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteologics Inc filed Critical Proteologics Inc
Publication of AU2002359792A1 publication Critical patent/AU2002359792A1/en
Publication of AU2002359792A8 publication Critical patent/AU2002359792A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002359792A 2001-12-18 2002-12-18 Methods and compositions for the inhibition of viral release Abandoned AU2002359792A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34156801P 2001-12-18 2001-12-18
US60/341,568 2001-12-18
US36264902P 2002-03-09 2002-03-09
US60/362,649 2002-03-09
PCT/US2002/041028 WO2003051835A2 (en) 2001-12-18 2002-12-18 Methods and compositions for the inhibition of viral release

Publications (2)

Publication Number Publication Date
AU2002359792A1 AU2002359792A1 (en) 2003-06-30
AU2002359792A8 true AU2002359792A8 (en) 2003-06-30

Family

ID=26992569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359792A Abandoned AU2002359792A1 (en) 2001-12-18 2002-12-18 Methods and compositions for the inhibition of viral release

Country Status (2)

Country Link
AU (1) AU2002359792A1 (en)
WO (1) WO2003051835A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003017943A2 (en) 2001-08-22 2003-03-06 Myriad Genetics, Inc Therapeutic compositions and methods for treating viral infection
US8992939B2 (en) 2003-07-11 2015-03-31 Novavax, Inc. Highly efficient influenza matrix (M1) proteins
US8506967B2 (en) 2003-07-11 2013-08-13 Novavax, Inc. Functional influenza virus like particles (VLPs)
US8080255B2 (en) 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
EP3126005A4 (en) 2014-03-31 2017-11-29 The Trustees Of The University Of Pennsylvania Novel antiviral compounds and methods using same
WO2017156146A1 (en) * 2016-03-08 2017-09-14 University Of Vermont And State Agricultural College Modified arenavirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
US5559209A (en) * 1993-02-18 1996-09-24 The General Hospital Corporation Regulator regions of G proteins
JPH08151396A (en) * 1994-11-28 1996-06-11 Teijin Ltd Hla-binding oligopeptide and immunomodulating agent containing the compound
US7202329B2 (en) * 2001-03-14 2007-04-10 Myriad Genetics, Inc. Tsg101-GAGp6 interaction and use thereof

Also Published As

Publication number Publication date
AU2002359792A1 (en) 2003-06-30
WO2003051835A2 (en) 2003-06-26
WO2003051835A3 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
EP1453536A4 (en) Composition for the preservation of viruses
GB0218157D0 (en) Compositions for controlled release
HK1084043A1 (en) Derivatives of aryl-quinazoline/aryl-2amino-phenylmethanone which promote the release of parathyroidhormone
AU2002357119A8 (en) Mitocidal compositions and methods
EP1395240A4 (en) Modification of the sustained release profile
IL157231A0 (en) Parasiticidal compositions and methods of use
EP1501352A4 (en) Methods and compositions for controlled release of drugs
AU2002357748A8 (en) Osteopontin-related compositions and methods
AU2002359792A8 (en) Methods and compositions for the inhibition of viral release
HUP0204417A3 (en) Oral ciprofloxacin-composition of controlled release
IL155360A0 (en) Processes for the isolation or purification of plavastatin and compositions containing plavastatin
AU2002303552A8 (en) Methods and compositions for prevention of angioproliferation
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU2002337843A8 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
AU2002366809A8 (en) Syn3 compositions and methods
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
AU2002365136A8 (en) Compositions and methods for controlled release
HUP0303418A3 (en) Inhibitors of papilloma virus
HUP0400022A2 (en) Oral composition comprising an extract from the bark of albizzia myriophylla
AU2002359869A8 (en) Pak5-related compositions and methods
IL154785A0 (en) Polymorphic form of finasteride and processes for the preparation thereof
AU2002360614A8 (en) Methods of inhibiting fertility
GB2394953B (en) Inhibition of replication factor C
HU0104528D0 (en) Process for the preparation and use of biocide compositions
ZA200409052B (en) Compositions and methods for the modification of gene expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase